MyFinsight
Home
Blog
About
TScan Therapeutics, Inc. (TCRX)
TScan Therapeutics, Inc. (TCRX)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
337.18%
Quick Ratio
337.18%
Cash Ratio
323.46%
Debt to Asset Ratio
59.74%
Unit: Thousand (K) dollars
Assets Breakdown
Cash and cash equivalents
Right-of-use assets
Property and equipment, net
Others
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
Operating lease liability, net o...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
100,156
128,057
152,406
169,506
Marketable securities
-
-
-
14,947
Prepaid expenses and other current assets
4,247
4,709
4,802
3,712
Total current assets
104,403
132,766
157,208
188,165
Property and equipment
-
-
30,276
-
Less accumulated depreciation and amortization
-
-
21,570
-
Property and equipment, net
7,743
8,120
8,706
9,303
Right-of-use assets
54,228
56,006
57,743
59,438
Restricted cash
5,031
5,031
5,031
5,031
Long-term deposit and other assets
47
68
101
288
Total assets
171,452
201,991
228,789
262,225
Accounts payable
3,122
2,303
1,241
6,353
Accrued expenses and other current liabilities
7,832
8,592
7,668
10,765
Operating lease liability, current portion
7,717
7,438
7,167
6,904
Deferred revenue, current portion
586
1,637
2,619
5,186
Current portion of long-term debt
11,707
-
-
-
Total current liabilities
30,964
19,970
18,695
29,208
Operating lease liability, net of current portion
50,397
52,445
54,437
56,304
Long-term debt, net
21,072
32,654
32,534
32,414
Other long term liabilities
-
-
-
278
Total liabilities
102,433
105,069
105,666
118,204
Common stock-Voting Common Stock
7
6
5
5
Common stock-Nonvoting Common Stock
1
1
1
1
Additional paid-in capital
632,898
630,443
627,979
625,898
Accumulated other comprehensive loss
-
-
-
2
Accumulated deficit
-563,887
-533,528
-504,862
-481,885
Total stockholders' equity
69,019
96,922
123,123
144,021
Total liabilities and stockholders' equity
171,452
201,991
228,789
262,225
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Cash and cash
equivalents
$100,156K
(-40.87%↓ Y/Y)
Prepaid expenses and
other current assets
$4,247K
(37.67%↑ Y/Y)
Total current assets
$104,403K
(-52.79%↓ Y/Y)
Right-of-use assets
$54,228K
(-11.24%↓ Y/Y)
Property and equipment,
net
$7,743K
(-18.67%↓ Y/Y)
Restricted cash
$5,031K
(0.00%↑ Y/Y)
Long-term deposit and
other assets
$47K
(-97.36%↓ Y/Y)
Total assets
$171,452K
(-42.57%↓ Y/Y)
Total liabilities and
stockholders' equity
$171,452K
(-42.57%↓ Y/Y)
Total liabilities
$102,433K
(-15.93%↓ Y/Y)
Total stockholders'
equity
$69,019K
(-60.94%↓ Y/Y)
Accumulated deficit
-$563,887K
(-26.38%↓ Y/Y)
Operating lease
liability, net of current...
$50,397K
(-13.28%↓ Y/Y)
Total current
liabilities
$30,964K
(-1.14%↓ Y/Y)
Long-term debt, net
$21,072K
(-34.75%↓ Y/Y)
Additional paid-in capital
$632,898K
(1.61%↑ Y/Y)
Common stock-Voting
Common Stock
$7K
(40.00%↑ Y/Y)
Common
stock-Nonvoting Common Stock
$1K
(0.00%↑ Y/Y)
Current portion of
long-term debt
$11,707K
Accrued expenses and
other current...
$7,832K
(-38.80%↓ Y/Y)
Operating lease
liability, current portion
$7,717K
(22.73%↑ Y/Y)
Accounts payable
$3,122K
(-31.22%↓ Y/Y)
Deferred revenue,
current portion
$586K
(-92.39%↓ Y/Y)
Buy us a coffee